Tratamento precoce do choque séptico com dexametasona: monitorização comparativa com proteína C-reativa e proteína amilóide A sérica / Septic shock early treatment with dexamethasone: comparative study with C-reactive protein and serum amyloid A protein

AUTOR(ES)

Domingos Dias Cicarelli

DATA DE PUBLICAÇÃO

2008

RESUMO

INTRODUCTION: Sepsis and septic shock are a very common condition in critically ill patients, leading to multiple organ dysfunction syndrome (MODS) and death. This study aimed at investigating the efficacy of early administration of dexamethasone in patients with septic shock in order to block the evolution to MODS and death. It also evaluated serum amyloid A protein (SAA) and C-reactive protein (CRP) as evolution and organ dysfunction markers in postoperative septic shock patients. METHODS: Prospective, randomized, double-blind study, developed in a surgical intensive care unit of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo that involved 29 patients with septic shock. All eligible patients were prospectively randomized to receive either a dose of 0.2 mg/kg of dexamethasone (group D) or placebo (group P), repeated every 36 hours intervals. Patients were monitored over a 7- day period by Sequential Organ Failure Assessment score (SOFA) and daily measurements of CRP, SAA and lactate. RESULTS: Patients treated with dexamethasone had more vasopressor therapy-free days (2.9±2.7 versus 0.7±0.6, p=0.01) and more mechanical ventilation-free days (2.6±2.5 e 0.6±0.5, p=0.03). Mortality in group P was 67% (10 in 15) and in group D was 21% (3 in 14) (Relative Risk=0.31, 95%CI 0.11 to 0.88). CRP and SAA were strongly correlated during the 7 day period of observation (R=0.91/p=0.002). CRP and SAA did not correlate with SOFA (respectively R=0.71/p=0.05 and R=0.52/p=0.18) and lactate (p=0.88 and p=0.67). CONCLUSIONS: Early treatment with dexamethasone reduced 7-day mortality in septic shock patients. CRP and SAA levels were significantly elevated in septic shock and were strongly correlated to each other, but did neither correlate with organ dysfunction nor predict mortality.

ASSUNTO(S)

proteína c-reativa adrenal cortex hormones c-reactive protein corticoesteróides septic shock serum amyloid a protein dexamethasone choque séptico dexametasona proteína amilóide a sérica

Documentos Relacionados

• Estudo das concentrações séricas de proteína C-reativa e amilóide A em cães com linfoma submetidos a quimioterapia
• Avaliação da concentração serica da proteina C-reativa na forma cardiaca da Doença de Chagas
• Análise comparativa dos níveis de proteína C-reativa altamente sensível entre indivíduos portadores e não portadores de lesão periapical crônica
• Correlação da composição de placas à histologia virtual com proteína C-reativa
• Proteína c-reativa e S100B na mania aguda